Carl Heneghan

Yeah, go on, fire away.

Sounds like that's a McDonald campaign for re-election, isn't it?

In the socialist agenda for research in healthcare.

Vote for me now or else.

Yeah, totally.

This is a really interesting, you know, I've listened to Fee's talk and it was interesting as she was talking.

It was a great talk.

In fact, it's available online.

So we might put the link as well on the webcast link.

So it's really interesting.

I suspect, and when I listened to it, I thought, and when I was hearing it, it jumped a little bit around.

But actually, I think what's happened here is.

I think there's been about a 20-year journey in the BMJ where this issue just keeps coming up and up.

And every few years it's been coming up.

And now it's like brewing to the top.

And there's been quite a lot in the last 12, 18 months.

And some things are happening like the cost of drugs is going through the roof, isn't it?

The commercial pressures are higher than ever.

We've moved beyond drugs to devices and to technologies, so the potential for commercialization is far greater than ever.

So all of this is creating a real big melting pot of problems that occur.